BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2021 Earnings Conference Call November 10, 2021 8:30 AM ET Company Participants Vimal Mehta - Chief Executive Officer Richard Steinhart - Chief Financial Officer Vincent O’Neill - Chief Medical Officer Frank Yocca - Chief Scientific Officer Rob Risinger - Senior Vice President, Clinical Development Conference Call Participants Greg Harrison - Bank of America Robyn Karnauskas - Truist Sumant Kulkarni - Canaccord Colin Bristow - UBS Ram Selvaraju - H.C. Wainwright E ...

NASDAQ: BTAI | --- | --- | --- | --- | --- | |--------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Developing Transformative Medicines Utilizing AI Approaches | | | | | | September 2021 | | | | | | | | | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation incl ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q2 2021 Results Conference Call August 10, 2021 8:30 AM ET Company Participants Dr. Vimal Mehta - CEO Richard Steinhart - CFO Will Kane - Chief Commercial Officer Dr. Vince O’Neill - Chief Medical Officer Dr. Frank Yocca - Chief Scientific Officer Dr. Rob Risinger - SVP, Clinical Development Conference Call Participants Greg Harrison - Bank of America Ram Selvaraju - H.C. Wainwright Eddie Hickman - Guggenheim Sumant Kulkarni - Canaccord Anita Dushyanth - Berenberg Ca ...

April 2021 NASDAQ: BTAI | --- | --- | --- | --- | --- | |--------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Developing Transformative Medicines Utilizing AI Approaches | | | | | | May 2021 | | | | | | | | | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2021 Earnings Conference Call May 10, 2021 8:30 AM ET Company Participants Vimal Mehta - Chief Executive Officer Richard Steinhart - Chief Financial Officer Will Kane - Chief Commercial Officer Frank Yocca - Chief Scientific Officer Vince O’Neill - Chief Medical Officer Reina Benabou - Chief Development Officer Conference Call Participants Greg Harrison - Bank of America Suzana Princy - Goldman Sachs Brian Mills - Jefferies Sumant Kulkarni - Canaccord Robyn Karnau ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2020 Earnings Conference Call March 11, 2021 8:30 AM ET Company Participants Vimal Mehta - Chief Executive Officer Richard Steinhart - Chief Financial Officer Will Kane - Chief Commercial Officer Frank Yocca - Chief Scientific Officer Vince O’Neill - Chief Medical Officer Reina Benabou - Chief Development Officer Conference Call Participants Geoff Meacham - Bank of America Graig Suvannavejh - Goldman Sachs Chris Howerton - Jefferies Sumant Kulkarni - Canaccord Rob ...

NASDAQ: BTAI | --- | --- | --- | --- | --- | --- | |----------------------------------------------------------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | Developing and Commercializing Innovative Medicines Discovered using AI November 2020 | | | | | | | | | | | | | | | | | | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking ...

Call Start: 08:30 January 1, 0000 9:10 AM ET BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2020 Earnings Conference Call November 12, 2020 08:30 ET Company Participants Vimal Mehta - Chief Executive Officer Richard Steinhart - Chief Financial Officer Will Kane - Chief Commercial Officer Reina Benabou - Chief Development Officer Vince O'Neill - Chief Medical Officer Robert Risinger - Senior Vice President of Clinical Development Frank Yocca - Chief Scientific Officer Conference Call Participants Geoff Meacham ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q2 2020 Earnings Conference Call August 14, 2020 8:30 AM ET Company Participants Vimal Mehta – Chief Executive Officer Michael Stanton – Controller Rob Risinger – Senior Vice President-Clinical Development Will Kane – Chief Commercial Officer Reina Benabou – Chief Development Officer Conference Call Participants Geoff Meacham – Bank of America Robyn Karnauskas – Truist Securities Yatin Suneja – Guggenheim Partners Sumant Kulkarni – Canaccord Ram Selvaraju – H.C. Wain ...

NASDAQ: BTAI | --- | --- | --- | --- | |-----------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | Next Wave of Medicines Utilizing AI June 2020 | | | | | | | | | | | | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation include, but are not limited to, statements that relate to the advancement a ...